Impaired activity of the fusogenic micropeptide Myomixer causes myopathy resembling Carey-Fineman-Ziter syndrome
Authors:
- Andres Ramirez-MartinezARAndres Ramirez-Martinez
- Yichi ZhangYZYichi Zhang
- Cristina Rodriguez-CaycedoCRCristina Rodriguez-Caycedo
- Andreas C. ChaiACAndreas C. Chai
- Francesco ChemelloFCFrancesco Chemello
- Inge CuppenICInge Cuppen
- Martin G. ElferinkMEMartin G. Elferink
- Robert J.J. van EsRERobert J.J. van Es
- Nard G. JanssenNJNard G. Janssen
Open Access
- 1 June 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 132 (11)
Abstract
Skeletal muscle fibers contain hundreds of nuclei, which increase the overall transcriptional activity of the tissue and perform specialized functions. Multinucleation occurs through myoblast fusion, mediated by the muscle fusogens Myomaker (MYMK) and Myomixer (MYMX). We describe a human pedigree harboring a recessive truncating variant of the MYMX gene that eliminates an evolutionarily conserved extracellular hydrophobic domain of MYMX, thereby impairing fusogenic activity. Homozygosity of this human variant resulted in a spectrum of abnormalities that mimicked the clinical presentation of Carey-Fineman-Ziter syndrome (CFZS), caused by hypomorphic MYMK variants. Myoblasts generated from patient-derived induced pluripotent stem cells displayed defective fusion, and mice bearing the human MYMX variant died perinatally due to muscle abnormalities. In vitro assays showed that the human MYMX variant conferred minimal cell-cell fusogenicity, which could be restored with CRISPR/Cas9–mediated base editing, thus providing therapeutic potential for this disorder. Our findings identify MYMX as a recessive, monogenic human disease gene involved in CFZS, and provide new insights into the contribution of myoblast fusion to neuromuscular diseases.Keywords
Funding Information
- Welch Foundation (1-0025)
- National Institutes of Health (HL-130253,HD-087351)
This publication has 57 references indexed in Scilit:
- Myomaker mediates fusion of fast myocytes in zebrafish embryosBiochemical and Biophysical Research Communications, 2014
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing SpecificityCell, 2013
- Myomaker is a membrane activator of myoblast fusion and muscle formationNature, 2013
- Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory responseNeuromuscular Disorders, 2012
- Myoblast fusion: lessons from flies and miceDevelopment, 2012
- Uncoordinated Transcription and Compromised Muscle Function in the Lmna-Null Mouse Model of Emery-Dreifuss Muscular DystrophyPLOS ONE, 2011
- Factors Involved in Regulating Trophoblast Fusion: Potential Role in the Development of PreeclampsiaPlacenta, 2009
- DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cellsJournal of Experimental Medicine, 2005
- The Carey–Fineman–Ziter syndrome: Follow‐up of the original siblings and comments on pathogenesisAmerican Journal of Medical Genetics Part A, 2004
- Modulation of Myoblast Fusion by Caveolin-3 in Dystrophic Skeletal Muscle Cells: Implications for Duchenne Muscular Dystrophy and Limb-Girdle Muscular Dystrophy-1CMolecular Biology of the Cell, 2003